Mostik AI, a full-stack, AI native drug discovery and development company, today announced the closing of a $26M Seed Extension and the addition of its new Co-Founder and Chief Technology Officer, Ujjwal Singh.
Mostik AI was founded to overcome the critical inefficiencies of traditional drug development. By uniting world-class biomedical expertise and next generation AI capabilities, the company is pioneering a new paradigm of faster, cheaper, and more precise medicines.
Mostik AI will utilize the new funding to accelerate the development of its drug discovery foundational models and advance its current therapeutic campaigns. Mostik AI will also utilize funds to continue to expand its team of premier interdisciplinary individuals, with new additions headed by Ujjwal Singh.
Singh joins Mostik AI having most recently served as Chief Technology and Product Officer at Multiverse. He previously held the role of Head of Workplace at Meta, following a distinguished tenure at Google where he drove significant product innovation. At Google, Singh was a Partner at the internal incubator, Area 120, and as Senior Director of Engineering, he founded and launched Google Hangouts. He also spearheaded the engineering efforts that expanded YouTube into dedicated platforms like YouTube Kids, Music, and Gaming.
“We are incredibly excited to welcome Ujjwal Singh as both a Co-Founder and Chief Technology Officer,” said Sasha Malysheva, CEO and Co-Founder of Mostik AI. “Ujjwal’s extensive AI and productization background perfectly complement the AI-native, scalable design of Mostik’ vision.”
“Mostik AI’s mission to usher in a new era of medicine—one defined by accelerated discovery and highly targeted therapies—deeply resonates with me,” said Singh. “Together with Reid Hoffman, Sasha Malysheva, and the rest of the remarkable leadership team, I believe we can build a truly meaningful company.”
“It is excellent to work with Ujjwal again. Ujjwal is an amazing technologist, who brings the experience of many scale AI projects to Mostik’ mission to transform the drug discovery process,” said Reid Hoffman, Co-Founder of Mostik AI, Inflection AI, and LinkedIn.
Mostik AI’s Seed Extension follows a $24.6M Seed Round announced in January of this year led by General Catalyst and Reid Hoffman. The seed extension also includes The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures, and a number of individuals.
About Mostik AI
Co-founded by Sasha Malysheva, Reid Hoffman, and Ujjwal Singh, Mostik AI builds and uses neuro-symbolic, science-based foundational models to discover and bring transformative medicines to market. Mostik AI is headquartered in New York City, NY.